jeudi 31 mars 2016

Onco Actu du 31 mars 2016

2. Etiologie

Common diabetes drug raises risk of developing cancer [The Telegraph]

3.1 Tabac

When is a smoker an adult? Why we shouldn’t raise the legal smoking age to 21 [The Conversation]

4.2 Dép., diag. & prono. - Génome

Children with cancer to get new gene test [The Institute of Cancer Research]

'Exciting' new genetic test for child cancer patients [BBC News]

4.5 Dép., diag. & prono. - Colorectal

Reminder letter encourages more people to take bowel scope screening test [Cancer Research UK]

5.12 Immunothérapies

Sanofi Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round [FierceBiotech]

5.12.2 Immunothérapies - CAR-T

Exploring the assessment and appraisal of regenerative medicines and cell therapy products [NICE]

5.2 Pharma

GSK Reaffirms Its Commitment To Oncology Research But The Strategy Is Unclear [Forbes]

5.2.1 Pharma - Partenariats

Boehringer Ingelheim Venture Fund invests in Amal Therapeutics to develop novel therapeutic colorectal cancer vaccine [Boehringer Ingelheim]

5.2.3 Pharma - économie

The price of health: the cost of developing new medicines [The Guardian]

5.3 Traitements - FDA, EMA,...

FDA Review Times Steadily Decreasing, Report Finds [RAPS]

European Medicines Agency Validates Bristol-Myers Squibb’s Application for Opdivo® (nivolumab) for the Treatment of Classical Hodgkin Lymphoma Patients [BMS]

5.3.4 Traitements - AMM (FDA, EMA)

FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow [FDA]

5.4 Traitements - Economie

Only Two Out of Ten Drugs? Really? [In the Pipeline]

Prominent doctors group supports controversial moves to lower drug prices [STAT]

6.10 Politiques

Curing Cancer Is Within Reach [Bloomberg]

Cancer And The Presidency: Why This CEO Says Each Candidate Needs A Plan [Forbes]